Century Therapeutics (IPSC) Interest & Investment Income (2022 - 2025)
Historic Interest & Investment Income for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to $1.6 million.
- Century Therapeutics' Interest & Investment Income fell 5143.72% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year decrease of 3459.0%. This contributed to the annual value of $13.0 million for FY2024, which is 260.31% up from last year.
- According to the latest figures from Q3 2025, Century Therapeutics' Interest & Investment Income is $1.6 million, which was down 5143.72% from $2.0 million recorded in Q2 2025.
- Century Therapeutics' 5-year Interest & Investment Income high stood at $3.6 million for Q2 2024, and its period low was $706000.0 during Q2 2022.
- Its 4-year average for Interest & Investment Income is $2.6 million, with a median of $2.9 million in 2024.
- Per our database at Business Quant, Century Therapeutics' Interest & Investment Income surged by 33314.45% in 2023 and then tumbled by 5143.72% in 2025.
- Century Therapeutics' Interest & Investment Income (Quarter) stood at $1.4 million in 2022, then surged by 148.76% to $3.5 million in 2023, then dropped by 17.92% to $2.9 million in 2024, then plummeted by 44.29% to $1.6 million in 2025.
- Its Interest & Investment Income was $1.6 million in Q3 2025, compared to $2.0 million in Q2 2025 and $2.4 million in Q1 2025.